Optimer Pharmaceuticals
company
Exit Type
M&A
Exit Date
Feb 16, 2007
Exit parties in this round
| Partner | Fund Round | Return Amount | Return Multiplier | |
|---|---|---|---|---|
| SB Life Science | Series D | — | — | Detail |
